BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21414664)

  • 1. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia.
    Iacobucci I; Sazzini M; Garagnani P; Ferrari A; Boattini A; Lonetti A; Papayannidis C; Mantovani V; Marasco E; Ottaviani E; Soverini S; Girelli D; Luiselli D; Vignetti M; Baccarani M; Martinelli G
    Leuk Res; 2011 Aug; 35(8):1052-9. PubMed ID: 21414664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
    Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
    Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
    Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
    J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.
    Cunnington MS; Santibanez Koref M; Mayosi BM; Burn J; Keavney B
    PLoS Genet; 2010 Apr; 6(4):e1000899. PubMed ID: 20386740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
    Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
    Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.
    Burd CE; Jeck WR; Liu Y; Sanoff HK; Wang Z; Sharpless NE
    PLoS Genet; 2010 Dec; 6(12):e1001233. PubMed ID: 21151960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.
    Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J
    Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
    Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population.
    Gutierrez-Camino A; Martin-Guerrero I; Garcia de Andoin N; Sastre A; Carbone Bañeres A; Astigarraga I; Navajas A; Garcia-Orad A
    PLoS One; 2017; 12(5):e0177421. PubMed ID: 28481918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
    Quesnel B
    Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Paoloni F; Trino S; Storlazzi CT; Ottaviani E; Cattina F; Impera L; Abbenante MC; Vignetti M; Vitale A; Potenza L; Paolini S; Soverini S; Pane F; Luppi M; Foà R; Baccarani M; Martinelli G
    Clin Cancer Res; 2011 Dec; 17(23):7413-23. PubMed ID: 22134481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 9p21 locus: A potential therapeutic target and prognostic marker in breast cancer.
    Rivandi M; Khorrami MS; Fiuji H; Shahidsales S; Hasanzadeh M; Jazayeri MH; Hassanian SM; Ferns GA; Saghafi N; Avan A
    J Cell Physiol; 2018 Jul; 233(7):5170-5179. PubMed ID: 29240242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin dependent kinase inhibitor 2A/B gene deletions are markers of poor prognosis in Indian children with acute lymphoblastic leukemia.
    Agarwal M; Bakhshi S; Dwivedi SN; Kabra M; Shukla R; Seth R
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27001. PubMed ID: 29446543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Yin and Yang-Like Clinical Implications of the
    González-Gil C; Ribera J; Ribera JM; Genescà E
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variants in the 9p21 region and their associations with multiple tumours.
    Gu F; Pfeiffer RM; Bhattacharjee S; Han SS; Taylor PR; Berndt S; Yang H; Sigurdson AJ; Toro J; Mirabello L; Greene MH; Freedman ND; Abnet CC; Dawsey SM; Hu N; Qiao YL; Ding T; Brenner AV; Garcia-Closas M; Hayes R; Brinton LA; Lissowska J; Wentzensen N; Kratz C; Moore LE; Ziegler RG; Chow WH; Savage SA; Burdette L; Yeager M; Chanock SJ; Chatterjee N; Tucker MA; Goldstein AM; Yang XR
    Br J Cancer; 2013 Apr; 108(6):1378-86. PubMed ID: 23361049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
    J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.
    Holdt LM; Beutner F; Scholz M; Gielen S; Gäbel G; Bergert H; Schuler G; Thiery J; Teupser D
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):620-7. PubMed ID: 20056914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study.
    Johnson AD; Hwang SJ; Voorman A; Morrison A; Peloso GM; Hsu YH; Thanassoulis G; Newton-Cheh C; Rogers IS; Hoffmann U; Freedman JE; Fox CS; Psaty BM; Boerwinkle E; Cupples LA; O'Donnell CJ
    Circulation; 2013 Feb; 127(7):799-810. PubMed ID: 23315372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.